Type
Offshoring/Delocalisation
Country
Ireland
Region
Southern and Eastern; South-East (IRL);
Location of affected unit(s)
Waterford
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
New offshoring locations
France, Germany

200 jobs
Number of planned job losses
Job loss
Announcement Date
14 March 2007
Employment effect (start)
Foreseen end date
31 December 2007

Description

The decision to close the French-owned Sanofi-Aventis plant in Waterford follows a review of global operations which will also see plant closures and disposals in Slovakia, Portugal, Spain and Italy. The pharmaceutical company blamed declining sales across Europe, excess manufacturing capacity, increased competition from generic products and "pressure from health authorities in a number of countries to reduce the prices paid for drugs". Production in Waterford of capsules to treat liver disease and gels and ointments to treat microbial conditions, will be transferred to plants in France and Germany. However, Michael McGrath, general manager, said Sanofi-Aventis "remains committed to Ireland" and plans to retain its commercial operations division which employs 140 people at Citywest in Dublin. Mr McGrath said the decision "in no way reflects on employee performance" but was a strategic decision.


Sources

  • 15 March 2007: The Irish Times

Citation

Eurofound (2007), Sanofi-Aventis, Offshoring/Delocalisation in Ireland, factsheet number 65102, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/65102.